http://www.hbl.co.il HBL announces a successful public offering on the TASE - over 11 million NIS raised Tue 31 Aug 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=75 "Hadasit Bio Holdings raises NIS 11.5m in TASE offering" Tue 31 Aug 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=76 Thrombotech, a subsidiary of Hadasit Bio Holdings, successfully completed Phase I trial Tue 24 Aug 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=74 The company reports first substantial capital gain of 13 million NIS Thu 19 Aug 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=72 Biomarcker Technologies, a subsidiary of Hadasit Bio-Holdings, has signed an exclusive licensing agreement with Hadasit for the commercialization of an innovative marker enabling early detection of cancer Mon 16 Aug 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=73 "The TASE BioMed Index's Favorite Seeking Partnerships" Sun 29 Jul 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=71 ProtAb, KAHR and CellCure included in the list Sat 14 Jun 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=70 Israel's only hospital affiliated biopark, located in Jerusalem, helps doctors conduct research Fri 13 Jun 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=69 9 Stocks on TASE Post Gains Even When the Market Doesn't Thu 19 Apr 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=68 The company is developing a novel monoclonal antibody for the treatment of Rheumatoid Arthritis and other autoimmune diseases such as Crohn's Disease Fri 13 Apr 2010 00:00:00 GMT http://www.hbl.co.il/press_item.asp?ID=67